Matthias Fröhlich

12PUBLICATIONS
48CO-AUTHORS
Rheumatology and arthritisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Clinical pharmacology and therapeuticsMedical infection agents (incl. prions)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Mar 04, 2026
Calprotectin and serum amyloid A for disease activity assessment in giant cell arteritis and polymyalgia rheumatica: results from a prospective single-centre cohort study.

Marc Schmalzing, Matthias Froehlich, Patrick P Strunz

|Jul 09, 2025
Comparison of T cell response to vaccination in rheumatic patients treated with Janus kinase inhibitors and TNF inhibitors.

Sebastian Hüper, Florian Eisele, Johannes Duell

|Apr 15, 2025
Janus kinase inhibitors show a longer drug survival than biologics in a real-world cohort of patients with rheumatoid arthritis - a retrospective analysis from the RHADAR database.

Linus Maximilian Risser, Torsten Witte, Matthias Englbrecht

|Jan 13, 2025
Isolated inflammatory involvement of the occipital artery in giant cell arteritis and polymyalgia rheumatica: findings from a retrospective analysis and the critical role of MRI in diagnosis.

Konstanze V Guggenberger, Lukas Riedling, Daria Kern

|Dec 11, 2024
Clonal T cell populations scarcely impair patients with rheumatic diseases: a prospective long-term follow up study.

Michael Gernert, Tobias Müller, Lukas Schweiker

|Aug 22, 2024
Vaccination status of patients with primary immunodeficiencies in Germany-a multicentric epidemiologic analysis.

Eva C Schwaneck, Anna S Harasim, Hans-Peter Tony

Pageof 2

Frequent Collaborators

9 joint publications

Patrick-Pascal Strunz

9 joint publications

Marc Schmalzing

9 joint publications

Michael Gernert

4 joint publications

Eva Christina Schwaneck